•Perioperative chemotherapy and stereotactic body radiotherapy versus perioperative chemotherapy alone in patients with high-risk, localised pancreatic cancer (MASTERPLAN): an open-label, phase 2, multicentre, randomised trial of the Australasian Gastro-Intestinal Trials Group
•The resveratrol prodrug triacetylresveratrol targets the intestinal tract to alleviate PEDV infection via the AMPK-ULK1 autophagy axis
•Advanced inflammatory bowel disease therapies in patients with recent solid malignancy: long-term outcomes in a propensity-matched cohort
•Whipple Disease: A Two-Decade Multisystem Masquerade Preceding Gastrointestinal Presentation
•The role of gut microbiota in paediatric short bowel syndrome
